These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31710438)

  • 21. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
    Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
    Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reliability of the thyroid stimulating hormone receptor antibodies level determination in diagnosing and prognosing of autoimmune hyperthyroidism].
    Aleksić AZ; Aleksić ZP; Mitov VM; Jović MJ
    Vojnosanit Pregl; 2009 Oct; 66(10):779-84. PubMed ID: 19938754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies.
    Yoshimura Noh J; Miyazaki N; Ito K; Takeda K; Hiramatsu S; Morita S; Miyauchi A; Murakami T; Inomata K; Noguchi S; Satoh T; Amino N
    Thyroid; 2008 Nov; 18(11):1157-64. PubMed ID: 19014323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
    Zimmermann-Belsing T; Nygaard B; Rasmussen AK; Feldt-Rasmussen U
    Eur J Endocrinol; 2002 Feb; 146(2):173-7. PubMed ID: 11834425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
    Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of thyroid antibodies].
    Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG
    Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three competitive immunoassays for measurement of TSH receptor antibodies in patients with Graves' disease.
    Doroudian S; Pedersen IB; Knudsen CS; Handberg A; Andersen SL
    Scand J Clin Lab Invest; 2017 Nov; 77(7):535-540. PubMed ID: 28737965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system.
    Kamijo K
    Endocr J; 2010; 57(10):895-902. PubMed ID: 20716835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.
    Tozzoli R; Bagnasco M; Giavarina D; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):107-13. PubMed ID: 22776786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of TSH receptor antibody concentrations and comparability of its immunoassays.
    Jansen HI; Gohy HG; Boelen A; Bisschop PH; Hillebrand JJ; Heijboer AC
    Clin Chim Acta; 2023 Aug; 548():117505. PubMed ID: 37543354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a third-generation TSH-receptor antibody in a UK clinic.
    Theodoraki A; Jones G; Parker J; Woolman E; Martin N; Perera S; Thomas M; Bunn C; Khoo B; Bouloux PM; Vanderpump MP
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):127-33. PubMed ID: 21521291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study.
    Struja T; Jutzi R; Imahorn N; Kaeslin M; Boesiger F; Kutz A; Mundwiler E; Huber A; Kraenzlin M; Mueller B; Meier C; Bernasconi L; Schuetz P
    BMC Endocr Disord; 2019 Apr; 19(1):38. PubMed ID: 31023276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [TSH anti-receptor antibodies in Graves' disease].
    Sérgio MR; Godinho C; Guerra L; Agapito A; Fonseca F; Costa C
    Acta Med Port; 1996; 9(7-9):229-31. PubMed ID: 9005701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.